Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "69ba96bb726d81b4833822bd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin Phosphate and Dapagliflozin",
"description": "ST-GLIPTIN DAPA 100/10: Complete Guide to Sitagliptin Phosphate and Dapagliflozin Tablets for Diabetes Management\n\nManaging blood sugar effectively is the cornerstone of living well with Type 2 Diabetes. As modern lifestyles continue to impact metabolic health, combination therapies are becoming increasingly important for achieving better and more stable glucose control. One such advanced and effective treatment is ST-GLIPTIN DAPA 100/10, a powerful combination of Sitagliptin Phosphate and Dapagliflozin Tablets.\n\nThis comprehensive, SEO-friendly, and humanized guide will help you understand everything about this medication—how it works, its uses, benefits, side effects, and why it is widely prescribed for diabetes care.\n\nWhat is ST-GLIPTIN DAPA 100/10?\n\nST-GLIPTIN DAPA 100/10 is a combination oral anti-diabetic medication that contains:\n\nSitagliptin (as Sitagliptin Phosphate) – 100 mg\n\nDapagliflozin – 10 mg\n\nThis dual-action formula is specifically designed to control blood sugar levels through two different mechanisms, offering a more comprehensive approach compared to single-drug therapies.\n\nHow Does ST-GLIPTIN DAPA 100/10 Work? (Mechanism of Action)\n\nThis combination works by targeting blood sugar control from two important pathways:\n\n✔ Sitagliptin (DPP-4 Inhibitor)\n\nIncreases incretin hormone levels\n\nStimulates insulin release when blood sugar is high\n\nReduces glucose production in the liver\n\n✔ Dapagliflozin (SGLT2 Inhibitor)\n\nRemoves excess glucose through urine\n\nReduces blood sugar levels independently of insulin\n\nHelps in calorie loss, supporting weight management\n\n👉 Together, they provide complementary and synergistic action, ensuring better and long-lasting glycemic control.\n\nUses of ST-GLIPTIN DAPA 100/10\n1. Management of Type 2 Diabetes\n\nThis medication is primarily used to:\n\nLower high blood sugar levels\n\nImprove glycemic control\n\nMaintain stable glucose levels throughout the day\n\n2. Combination Therapy Support\n\nIt is ideal for patients who:\n\nAre not achieving control with a single medication\n\nNeed a more advanced treatment approach\n\n3. Prevention of Diabetes-Related Complications\n\nEffective blood sugar control helps reduce the risk of:\n\nHeart disease\n\nKidney damage\n\nNerve disorders\n\nVision problems\n\nKey Benefits of ST-GLIPTIN DAPA 100/10\n✔ 1. Dual Mechanism Action\n\nControls blood sugar through insulin-dependent and independent pathways.\n\n✔ 2. Better Glycemic Control\n\nReduces both fasting and post-meal sugar levels.\n\n✔ 3. Weight Management Support\n\nDapagliflozin helps in mild weight reduction.\n\n✔ 4. Low Risk of Hypoglycemia\n\nLess likely to cause low blood sugar when used alone.\n\n✔ 5. Cardiovascular Benefits\n\nMay reduce risk of heart-related complications.\n\nAdditional Advantages\n\nImproves HbA1c levels effectively\n\nPromotes glucose excretion naturally\n\nConvenient once-daily dosing\n\nEnhances overall metabolic health\n\nDosage and Administration\n\nTake ST-GLIPTIN DAPA 100/10 exactly as prescribed by your doctor\n\nUsually taken once daily, with or without food\n\nSwallow the tablet whole with water\n\nMaintain proper hydration due to increased urination\n\n⚠️ Do not stop or change dosage without medical advice.\n\nSide Effects of ST-GLIPTIN DAPA 100/10\n\nLike all medications, this combination may cause side effects in some individuals.\n\nCommon Side Effects\n\nIncreased urination\n\nThirst\n\nHeadache\n\nMild stomach discomfort\n\nNasal congestion\n\nThese are generally mild and temporary.\n\nSerious Side Effects\n\nUrinary tract infections (UTIs)\n\nGenital infections\n\nDehydration\n\nPancreatitis\n\nAllergic reactions\n\n⚠️ Seek immediate medical attention if severe symptoms occur.\n\nPrecautions and Warnings\n\nBefore taking this medication, inform your doctor if you have:\n\nKidney disease\n\nLiver problems\n\nHistory of infections\n\nHeart conditions\n\nImportant Safety Tips:\n\nDrink plenty of water\n\nMaintain proper hygiene to prevent infections\n\nMonitor blood sugar regularly\n\nAvoid excessive alcohol consumption\n\nWho Should Avoid This Medicine?\n\nThis medication may not be suitable for:\n\nPatients with Type 1 Diabetes\n\nIndividuals with diabetic ketoacidosis\n\nSevere kidney disease patients\n\nPeople allergic to its components\n\nLifestyle Tips for Better Results\n\nFor optimal results with ST-GLIPTIN DAPA 100/10:\n\n✔ Healthy Diet\n\nInclude whole grains, vegetables, and lean proteins.\n\n✔ Regular Exercise\n\nImproves insulin sensitivity and overall health.\n\n✔ Weight Management\n\nMaintain a healthy body weight.\n\n✔ Routine Monitoring\n\nKeep track of blood sugar and HbA1c levels.\n\nWhy Choose ST-GLIPTIN DAPA 100/10?\n\nThis medication stands out due to:\n\nAdvanced combination therapy\n\nEffective dual mechanism\n\nConvenience of single-tablet dosing\n\nBetter patient compliance\n\nConclusion\n\nManaging Type 2 Diabetes requires a comprehensive approach, and ST-GLIPTIN DAPA 100/10 (Sitagliptin Phosphate and Dapagliflozin Tablets) offers exactly that.\n\nWith its dual-action formula, it helps:\n\nControl blood sugar effectively\nReduce complications\nImprove overall quality of life\nHowever, it should always be used under proper medical supervision along with a healthy lifestyle.",
"price": 421.0,
"discountamount": 126.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2342,
"imageuri": "https://productimages.withfloats.com/actual/69ba96be110dc9c055aa44ed.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69ba96be110dc9c055aa44ed.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-03-18T12:12:43.51Z",
"updatedon": "2026-06-09T12:10:51.175Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-phosphate-and-dapagliflozin/2342",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST- GLIPTIN DAPA 100/10",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin Phosphate and Dapagliflozin",
"sitagliptin phosphate and dapagliflozin tablets",
"sitagliptin phosphate and dapagliflozin tablets uses",
"sitagliptin dapagliflozin combination benefits",
"sitagliptin phosphate dapagliflozin tablets for diabetes",
"sitagliptin dapagliflozin combination review",
"dual therapy tablets for blood sugar control",
"diabetes treatment without insulin tablets",
"what is sitagliptin phosphate and dapagliflozin used for",
"buy sitagliptin phosphate and dapagliflozin tablets online",
"sitagliptin dapagliflozin tablets price in india",
"buy sitagliptin dapagliflozin tablets",
"where to buy sitagliptin dapagliflozin tablets",
"sitagliptin dapagliflozin bulk order india",
"best sitagliptin dapagliflozin tablets brand"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "698d91909e3c03f732124005",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Remogliflozin Etabonate Tablets 100 mg",
"description": "REMOFLOZIN 100 is an advanced oral antidiabetic medication containing Remogliflozin Etabonate 100 mg as its active pharmaceutical ingredient. This innovative formulation represents a significant breakthrough in the management of Type 2 Diabetes Mellitus, offering patients a novel mechanism of action that works independently of insulin secretion or insulin sensitivity. REMOFLOZIN 100 belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitors class of medications, which has revolutionized diabetes management by targeting glucose reabsorption in the kidneys rather than affecting pancreatic function or peripheral glucose utilization.\nDeveloped through rigorous scientific research and clinical trials, REMOFLOZIN 100 provides diabetic patients with an effective therapeutic option that not only helps control blood sugar levels but also offers additional cardiovascular and metabolic benefits. Each tablet is precisely formulated to deliver consistent and reliable glycemic control, making it an essential component in the comprehensive management of Type 2 Diabetes.\nHow REMOFLOZIN 100 Works\nThe mechanism of action of REMOFLOZIN 100 is both unique and highly effective. Under normal physiological conditions, the kidneys filter glucose from the blood, but the SGLT2 proteins in the proximal renal tubules reabsorb approximately 90% of this filtered glucose back into the bloodstream. In diabetic patients, this reabsorption continues even when blood glucose levels are elevated, perpetuating hyperglycemia.\nRemogliflozin Etabonate works by selectively inhibiting the SGLT2 proteins in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion. This insulin-independent mechanism allows the body to eliminate excess glucose naturally through urine, leading to sustained reductions in blood glucose levels. The medication typically begins working within hours of administration, with maximum therapeutic effects observed within several weeks of consistent use.\nPrimary Uses and Indications\nREMOFLOZIN 100 is primarily indicated for:\nManagement of Type 2 Diabetes Mellitus: As monotherapy in patients who cannot tolerate metformin or for whom metformin is contraindicated, and as combination therapy with other antidiabetic agents including metformin, sulfonylureas, or insulin when existing treatment regimens fail to achieve adequate glycemic control.\nGlycemic Control Optimization: For patients requiring additional blood sugar management beyond diet and exercise modifications, REMOFLOZIN 100 helps reduce both fasting plasma glucose and postprandial glucose levels.\nAdjunct to Lifestyle Modifications: The medication works synergistically with dietary modifications and regular physical activity to achieve comprehensive diabetes management and reduce the risk of long-term diabetic complications.\nKey Benefits of REMOFLOZIN 100\nSuperior Glycemic Control\nREMOFLOZIN 100 demonstrates significant efficacy in reducing HbA1c levels, typically achieving reductions of 0.5% to 1.0% when used as monotherapy and even greater reductions when combined with other antidiabetic medications. This improvement in long-term glucose control translates to reduced risk of microvascular complications, including diabetic retinopathy, nephropathy, and neuropathy.\nWeight Management Support\nUnlike many traditional antidiabetic medications that may cause weight gain, REMOFLOZIN 100 is associated with modest weight loss, typically ranging from 2 to 4 kilograms over several months of treatment. This weight reduction occurs due to caloric loss through urinary glucose excretion and may provide additional metabolic benefits for overweight or obese diabetic patients.\nCardiovascular Benefits\nEmerging research on SGLT2 inhibitors suggests potential cardiovascular protective effects, including modest reductions in blood pressure and improvements in various cardiovascular risk markers. These benefits may be particularly valuable for diabetic patients who are at increased risk of cardiovascular disease.\nLow Risk of Hypoglycemia\nBecause REMOFLOZIN 100 works independently of insulin secretion, it carries a minimal risk of hypoglycemia when used as monotherapy. This safety profile makes it particularly suitable for elderly patients or those at higher risk of dangerous low blood sugar episodes.\nRenal Function Considerations\nThe medication may offer nephroprotective benefits by reducing intraglomerular pressure and proteinuria in diabetic patients, potentially slowing the progression of diabetic kidney disease.\nConvenient Once-Daily Dosing\nREMOFLOZIN 100's pharmacokinetic profile allows for convenient once-daily administration, improving patient compliance and treatment adherence.\nPotential Side Effects and Safety Considerations\nWhile REMOFLOZIN 100 is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects\n\nGenital Mycotic Infections: Increased glucose in urine may promote fungal infections, particularly in women\nUrinary Tract Infections: More frequent urination and glucose in urine may increase UTI risk\nIncreased Urination: Polyuria is expected due to the medication's mechanism of action\nThirst: Patients may experience increased thirst due to fluid loss\nDizziness: Particularly when standing up quickly, due to mild blood pressure reductions\n\nSerious but Rare Side Effects\n\nDiabetic Ketoacidosis: Although rare, euglycemic DKA has been reported with SGLT2 inhibitors\nAcute Kidney Injury: Dehydration may affect kidney function in susceptible individuals\nLower Limb Amputation: Some SGLT2 inhibitors have shown increased risk in specific populations\nHypotension: Particularly in patients on diuretics or with compromised cardiovascular function\n\nContraindications and Precautions\nREMOFLOZIN 100 should not be used in patients with type 1 diabetes, severe renal impairment, diabetic ketoacidosis, or those with known hypersensitivity to the drug. Pregnant and breastfeeding women should avoid this medication. Patients should maintain adequate hydration and practice proper genital hygiene to minimize infection risks.\nDosage and Administration Guidelines\nThe standard recommended dose is one REMOFLOZIN 100 tablet taken orally once daily, preferably at the same time each day. The medication can be taken with or without food. Patients should not double doses if they miss a scheduled dose but should take the next dose at the regular time. Dosage adjustments may be necessary based on individual response, renal function, and concomitant medications. Regular monitoring of blood glucose levels, kidney function, and HbA1c is essential for optimal treatment management.\nConclusion\nREMOFLOZIN 100 represents a valuable therapeutic advancement in type 2 diabetes management, offering patients an innovative approach to glycemic control through its unique renal mechanism of action. The medication's ability to reduce blood sugar levels while providing additional benefits such as weight loss, cardiovascular protection, and low hypoglycemia risk makes it an attractive option for many diabetic patients.",
"price": 335.0,
"discountamount": 101.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2301,
"imageuri": "https://productimages.withfloats.com/actual/698d9191cd6033ecce84b352.png",
"tileimageuri": "https://productimages.withfloats.com/tile/698d9191cd6033ecce84b352.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-12T08:38:40.037Z",
"updatedon": "2026-03-13T11:02:30.281Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//remogliflozin-etabonate-tablets-100-mg/2301",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "REMOFLOZIN 100",
"category": "DIABETIC RANGE",
"tags": [
"Remogliflozin Etabonate 100mg tablets for type 2 diabetes",
"Remogliflozin 100mg oral diabetes medication",
"Remogliflozin Etabonate tablets 100mg prescription",
"Remogliflozin 100 mg SGLT2 inhibitor tablets",
"Remogliflozin Etabonate 100mg diabetes control tablets",
"Buy Remogliflozin 100mg tablets online",
"Remogliflozin Etabonate 100mg pack price",
"Remogliflozin 100mg tablets for blood sugar management"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6960c83f3056ad8a5a1aecba",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Cinnarizine and Domperidone Tablets ",
"description": "CLANARIZINE DOM represents an advanced pharmaceutical combination that brings together two potent therapeutic agents—Cinnarizine and Domperidone—in a single convenient tablet formulation. This innovative combination medication addresses multiple aspects of vestibular disorders, motion sickness, and associated nausea and vomiting, providing comprehensive relief for patients suffering from these debilitating conditions. Manufactured under stringent quality control standards, CLANARIZINE DOM offers a synergistic approach to managing symptoms that significantly impact quality of life and daily functioning.The combination of Cinnarizine and Domperidone in CLANARIZINE DOM is based on sound pharmacological principles. While Cinnarizine works primarily on the vestibular system to reduce dizziness and vertigo, Domperidone acts as an effective antiemetic to control nausea and vomiting. Together, these two active ingredients provide more comprehensive symptom control than either agent alone, making CLANARIZINE DOM an excellent choice for patients experiencing vestibular disturbances accompanied by gastrointestinal symptoms.This combination therapy is particularly valuable because vertigo, dizziness, and motion sickness are frequently accompanied by nausea and vomiting. Patients suffering from these conditions often find that addressing only one aspect of their symptoms provides insufficient relief. CLANARIZINE DOM's dual-action formula tackles both the underlying vestibular dysfunction and the accompanying gastrointestinal distress, offering patients a more complete therapeutic solution that improves both comfort and functional capacity.Understanding the Active IngredientsCinnarizine is a calcium channel blocker with specific antihistaminic and vestibular suppressant properties. Unlike systemic calcium channel blockers used for cardiovascular conditions, Cinnarizine selectively acts on the blood vessels in the inner ear and brain, improving blood flow to these areas. This enhanced circulation helps reduce the frequency and severity of vertigo attacks while also preventing motion sickness. Cinnarizine also possesses mild antihistaminic effects that contribute to its anti-nausea properties, though this is not its primary mechanism of action.The medication works by blocking calcium channels in the vestibular system, which helps stabilize the sensory organs responsible for balance. By reducing the excessive stimulation of the vestibular apparatus, Cinnarizine decreases the sensation of spinning or imbalance that characterizes vertigo. Additionally, its vasodilatory effects improve microcirculation in the inner ear, which can be beneficial for conditions where reduced blood flow contributes to symptoms.Domperidone is a peripheral dopamine antagonist that acts primarily as a prokinetic and antiemetic agent. Unlike some antiemetic medications that cross the blood-brain barrier and cause sedation or extrapyramidal side effects, Domperidone works predominantly in the peripheral nervous system. It blocks dopamine receptors in the chemoreceptor trigger zone (CTZ) located outside the blood-brain barrier, effectively preventing nausea and vomiting without causing significant central nervous system effects.Domperidone also enhances gastrointestinal motility by promoting coordinated contractions of the stomach and upper small intestine. This prokinetic effect helps empty the stomach more efficiently, reducing feelings of fullness, bloating, and discomfort that often accompany vestibular disorders. By accelerating gastric emptying, Domperidone also reduces the likelihood of gastroesophageal reflux, which can exacerbate nausea in some patients.The combination of these two medications in CLANARIZINE DOM creates a complementary therapeutic effect. While Cinnarizine addresses the vestibular component of dizziness and vertigo, Domperidone manages the gastrointestinal symptoms that frequently accompany these conditions. This dual approach provides more comprehensive symptom relief and improves overall treatment outcomes compared to monotherapy with either agent alone.Clinical Applications and UsesCLANARIZINE DOM is indicated for a wide range of conditions characterized by vertigo, dizziness, and associated nausea. Understanding these clinical applications helps healthcare providers select appropriate candidates for this combination therapy.Vestibular Disorders: The primary indication for CLANARIZINE DOM includes various vestibular disorders that cause vertigo and imbalance. These conditions include Ménière's disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis. Patients with these disorders experience episodes of spinning sensation, loss of balance, and often severe nausea. CLANARIZINE DOM helps reduce the frequency and intensity of vertigo attacks while controlling the accompanying gastrointestinal symptoms.Motion Sickness: CLANARIZINE DOM is highly effective for preventing and treating motion sickness, whether related to travel by car, boat, airplane, or amusement park rides. The medication can be taken prophylactically before travel or at the onset of symptoms. The combination is particularly useful for individuals who experience severe nausea and vomiting with motion sickness, as Domperidone provides powerful antiemetic effects that complement Cinnarizine's anti-motion-sickness properties.Migraine-Associated Vertigo: Many patients with migraines experience vestibular symptoms, including dizziness, vertigo, and motion sensitivity, either during migraine attacks or as independent episodes. CLANARIZINE DOM can help manage these vestibular manifestations of migraine, reducing both the vertigo and the nausea that often accompany migraine headaches.Post-Concussion Syndrome: Following head injuries, some patients develop persistent dizziness, balance problems, and nausea as part of post-concussion syndrome. CLANARIZINE DOM may provide symptomatic relief for these patients during their recovery period, though it should be used as part of a comprehensive treatment approach that includes rest, gradual return to activities, and vestibular rehabilitation when appropriate.Cerebrovascular Insufficiency: In older adults with reduced blood flow to the brain, symptoms such as dizziness, vertigo, tinnitus (ringing in the ears), and cognitive difficulties may develop. Cinnarizine's vasodilatory properties can improve cerebral circulation, potentially reducing these symptoms. The addition of Domperidone helps manage any associated nausea.Radiation-Induced or Chemotherapy-Induced Nausea: While not a primary indication, some healthcare providers use CLANARIZINE DOM as adjunctive therapy for patients undergoing cancer treatment who experience both nausea and dizziness. Domperidone's strong antiemetic properties are particularly valuable in this context.Key Benefits of CLANARIZINE DOMThe unique combination of Cinnarizine and Domperidone in CLANARIZINE DOM offers numerous advantages that make it a preferred choice for managing vestibular disorders and associated symptoms.Comprehensive Symptom Control: The primary benefit of CLANARIZINE DOM is its ability to address multiple symptoms simultaneously. Rather than requiring patients to take separate medications for vertigo and nausea, this combination provides unified treatment in a single tablet. This comprehensive approach improves symptom control across the full spectrum of vestibular disorder manifestations, from the spinning sensation to the gastrointestinal distress that often accompanies it.Improved Patient Compliance: Taking multiple medications can be burdensome, particularly for patients who feel dizzy or nauseated. CLANARIZINE DOM simplifies the treatment regimen by combining two medications in one tablet, making it easier for patients to adhere to their prescribed therapy. Better compliance translates to better outcomes, as consistent medication use is essential for managing chronic vestibular conditions.Synergistic Therapeutic Effects: The combination of Cinnarizine and Domperidone creates synergistic effects that enhance overall efficacy. While Cinnarizine reduces vestibular stimulation and improves inner ear blood flow, Domperidone prevents nausea and promotes gastric emptying. This dual action addresses both the cause and consequences of vestibular dysfunction, providing more complete relief than either medication alone.Reduced Central Nervous System Side Effects: Because Domperidone works primarily in the peripheral nervous system rather than crossing the blood-brain barrier extensively, CLANARIZINE DOM causes less sedation and fewer cognitive effects compared to some alternative antiemetic medications. This allows patients to maintain better alertness and function during treatment, which is particularly important for those who need to continue working or performing daily activities.Enhanced Quality of Life: Vertigo and chronic dizziness significantly impair quality of life, limiting mobility, social interactions, and occupational functioning. The nausea and vomiting that accompany these conditions add another layer of disability. By effectively controlling both vestibular and gastrointestinal symptoms, CLANARIZINE DOM helps restore patients' ability to engage in normal activities, improving overall life satisfaction and functional independence.Fast Onset of Action: CLANARIZINE DOM provides relatively rapid symptom relief, with many patients experiencing improvement within 30 minutes to 2 hours after taking the medication. This quick onset is particularly valuable for acute episodes of vertigo or when taking the medication prophylactically before situations that might trigger motion sickness.Suitable for Long-Term Use: For patients with chronic vestibular disorders requiring ongoing treatment, CLANARIZINE DOM is generally safe for extended use when properly monitored by a healthcare provider. The medication maintains its effectiveness over time without significant tolerance development, making it suitable for long-term symptom management.Improved Gastric Emptying: The prokinetic effects of Domperidone benefit not only nausea but also other gastrointestinal symptoms such as early satiety, bloating, and upper abdominal discomfort. Patients with vestibular disorders often develop gastroparesis or delayed gastric emptying secondary to their condition, and Domperidone addresses this issue effectively.Vascular Benefits: Cinnarizine's ability to improve blood flow to the inner ear and brain provides additional benefits beyond symptom control. Enhanced microcirculation may support healing and recovery in conditions where vascular insufficiency contributes to vestibular dysfunction.Side Effects and Safety ConsiderationsLike all medications, CLANARIZINE DOM can cause side effects, though not everyone experiences them. Understanding potential adverse effects helps patients recognize when to seek medical attention and allows healthcare providers to monitor therapy appropriately.Common Side Effects:The most frequently reported side effect of CLANARIZINE DOM is drowsiness or sedation, occurring in approximately 10-20% of patients. This effect is primarily attributable to Cinnarizine's antihistaminic properties. Patients should avoid driving or operating machinery until they know how the medication affects them. Taking the medication at bedtime can minimize daytime drowsiness for some patients.Dry mouth is another common side effect, affecting roughly 10-15% of patients. This occurs due to anticholinergic effects and can be managed by sipping water frequently, chewing sugar-free gum, or using saliva substitutes if severe. Maintaining good oral hygiene is important to prevent dental problems associated with reduced saliva production.Mild gastrointestinal symptoms, including constipation, abdominal discomfort, or changes in bowel habits, may occur. While Domperidone promotes gastric emptying, it can occasionally alter bowel motility. These effects are usually mild and resolve with continued use or dose adjustment.",
"price": 55.0,
"discountamount": 17.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2271,
"imageuri": "https://productimages.withfloats.com/actual/6960c8410b0da405bc908e58.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6960c8410b0da405bc908e58.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-01-09T09:19:59.281Z",
"updatedon": "2026-03-12T09:24:10.244Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//cinnarizine-and-domperidone-tablets-/2271",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CLANARIZINE DOM",
"category": "NEUROLOGY RANGE",
"tags": [
"cinnarizine and domperidone tablet uses",
"what is cinnarizine & domperidone tablet used for",
"cinnarizine domperidone combination medicine benefits",
"how cinnarizine domperidone tablet works",
"cinnarizine domperidone tablet for vertigo treatment",
"cinnarizine domperidone tablet for inner ear problem",
"cinnarizine domperidone tablet for balance disorder",
"cinnarizine domperidone tablet for travel sickness",
"cinnarizine domperidone tablet for gastric nausea",
"cinnarizine & domperidone tablet price in india",
"cinnarizine domperidone tablet brand name",
"cinnarizine domperidone tablet manufacturer in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "694d14f6274fc8b97e9b7120",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Mirtazapine 30mg",
"description": "MIRTAZPRIME 30 is a pharmaceutical formulation containing Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards. This prescription medication belongs to a class of drugs known as tetracyclic antidepressants and represents an advanced therapeutic option for individuals struggling with major depressive disorder and related mental health conditions. Manufactured under stringent quality control measures, MIRTAZPRIME 30 offers patients a reliable and effective solution for managing depression while also addressing associated symptoms such as insomnia and anxiety.\nMirtazapine, the active pharmaceutical ingredient in MIRTAZPRIME 30, works through a unique dual mechanism that distinguishes it from other antidepressants. Unlike selective serotonin reuptake inhibitors (SSRIs), mirtazapine enhances the release of both norepinephrine and serotonin in the brain by blocking specific receptors. This innovative approach not only helps alleviate depressive symptoms but also provides sedative effects that can be particularly beneficial for patients experiencing sleep disturbances alongside depression.\nTherapeutic Uses and Applications\nMIRTAZPRIME 30 is primarily indicated for the treatment of major depressive disorder (MDD), a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities. The medication has demonstrated significant efficacy in clinical trials, showing improvement in mood, energy levels, and overall quality of life for patients suffering from depression.\nBeyond its primary indication, healthcare providers may prescribe MIRTAZPRIME 30 for various off-label uses based on clinical judgment and patient needs. The medication has shown promise in managing generalized anxiety disorder, where excessive worry and tension interfere with daily functioning. Its sedative properties make it particularly valuable for patients experiencing insomnia related to depression or anxiety, as it can help restore healthy sleep patterns without the need for additional sleep medications.\nThe 30mg dosage strength represents a therapeutic level commonly prescribed for maintenance treatment after initial dose titration. Patients typically begin with lower doses and gradually increase to 30mg as their body adjusts to the medication and their symptoms require more robust management. This dosage provides an optimal balance between therapeutic efficacy and side effect management for many individuals.\nMIRTAZPRIME 30 may also be considered for patients who have not responded adequately to other antidepressant therapies, offering an alternative mechanism of action that can break through treatment-resistant depression. Additionally, its appetite-stimulating effects can be beneficial for patients experiencing significant weight loss due to depression or other medical conditions.\nKey Benefits and Therapeutic Advantages\nThe benefits of MIRTAZPRIME 30 extend beyond simple symptom relief, offering patients a multifaceted approach to mental health recovery. One of the most significant advantages is its relatively rapid onset of action compared to many other antidepressants. While most SSRIs require several weeks to demonstrate meaningful clinical improvement, patients taking mirtazapine often experience some relief from symptoms within one to two weeks, with continued improvement over subsequent weeks.\nThe dual neurotransmitter action of MIRTAZPRIME 30 provides comprehensive coverage of depressive symptoms. By enhancing both serotonergic and noradrenergic neurotransmission, the medication addresses the complex neurochemical imbalances underlying depression more thoroughly than single-mechanism antidepressants. This broader action can result in more complete symptom resolution and better overall outcomes.\nSleep improvement represents another crucial benefit of MIRTAZPRIME 30. The medication's sedative properties, particularly pronounced at lower doses, help patients fall asleep faster and enjoy more restorative sleep throughout the night. This is especially valuable since sleep disturbances are both a symptom and an exacerbating factor in depression. Better sleep quality contributes to improved daytime functioning, energy levels, and emotional regulation.\nUnlike many antidepressants that commonly cause sexual dysfunction, MIRTAZPRIME 30 has a relatively favorable profile in this regard. The medication is less likely to interfere with sexual function, making it an attractive option for patients who have experienced these troublesome side effects with other antidepressants. This characteristic can significantly improve treatment adherence and quality of life.\nThe appetite-stimulating effect, while considered a side effect by some, can be therapeutically beneficial for patients experiencing significant weight loss or poor appetite due to depression. MIRTAZPRIME 30 can help restore healthy eating patterns and reverse the physical decline that often accompanies severe depressive episodes.\nFurthermore, MIRTAZPRIME 30 does not typically cause the gastrointestinal side effects commonly associated with SSRI antidepressants, such as nausea, diarrhea, or stomach upset. This improved gastrointestinal tolerability enhances patient comfort and compliance with treatment regimens.\nPotential Side Effects and Safety Considerations\nWhile MIRTAZPRIME 30 offers numerous therapeutic benefits, patients should be aware of potential side effects that may occur during treatment. Understanding these effects helps patients make informed decisions and enables early identification of any concerning symptoms requiring medical attention.\nThe most commonly reported side effect is drowsiness or sedation, particularly during the initial weeks of treatment. This effect is typically most pronounced during the first few hours after taking the medication, which is why it's generally recommended for evening administration. Patients should exercise caution when driving, operating machinery, or engaging in activities requiring alertness until they understand how the medication affects them personally.\nIncreased appetite and weight gain represent another frequent side effect of MIRTAZPRIME 30. While beneficial for some patients, others may find this effect undesirable. Weight gain typically ranges from moderate to significant and appears to be dose-related. Patients concerned about weight should discuss dietary strategies and exercise plans with their healthcare provider.\nDry mouth is a common anticholinergic side effect that can cause discomfort but is generally manageable through increased fluid intake, sugar-free gum or candy, and good oral hygiene practices. Some patients may also experience dizziness, particularly when standing up quickly, due to the medication's effects on blood pressure regulation.\nConstipation may occur in some patients and can usually be managed through dietary modifications, increased fiber intake, adequate hydration, and regular physical activity. Less commonly, patients might experience confusion, abnormal dreams, or changes in thinking, particularly in older adults who may be more sensitive to the medication's effects.\nSerious side effects, while rare, require immediate medical attention. These include signs of allergic reactions such as rash, itching, swelling, severe dizziness, or difficulty breathing. Agranulocytosis, a dangerous decrease in white blood cells, is an extremely rare but serious complication that manifests as fever, sore throat, or signs of infection. Any unexplained fever or signs of infection should prompt immediate contact with a healthcare provider.\nSerotonin syndrome is another rare but potentially life-threatening condition that can occur when mirtazapine is combined with other medications affecting serotonin levels. Symptoms include agitation, hallucinations, rapid heartbeat, fever, excessive sweating, muscle stiffness, or coordination problems. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid dangerous interactions.\nAbrupt discontinuation of MIRTAZPRIME 30 can lead to withdrawal symptoms, including nausea, anxiety, irritability, and flu-like symptoms. Therefore, any decision to stop the medication should be made in consultation with a healthcare provider who can develop an appropriate tapering schedule.\nImportant Usage Guidelines\nMIRTAZPRIME 30 should always be taken exactly as prescribed by a qualified healthcare professional. The medication is typically administered once daily, preferably in the evening before bedtime due to its sedative effects. Tablets should be swallowed whole with water and can be taken with or without food, though taking them with food may help reduce any stomach upset.\nConsistency in timing is important for maintaining stable blood levels of the medication and optimizing therapeutic effects. Patients should try to take their dose at approximately the same time each evening. If a dose is missed, it should be taken as soon as remembered unless it's close to the time for the next scheduled dose, in which case the missed dose should be skipped rather than doubling up.\nThe full therapeutic benefits of MIRTAZPRIME 30 may take several weeks to manifest. Patients should continue taking the medication as prescribed even if they don't feel immediate improvement. Premature discontinuation is a common reason for treatment failure in depression management.\nRegular follow-up appointments with the prescribing physician are essential for monitoring treatment response, adjusting dosages if necessary, and screening for potential side effects. Patients should maintain open communication with their healthcare team about their symptoms, concerns, and any changes in their condition.\nConclusion\nMIRTAZPRIME 30 represents a valuable therapeutic option in the comprehensive management of major depressive disorder and related conditions. Its unique mechanism of action, combining enhanced noradrenergic and serotonergic neurotransmission with sedative and appetite-stimulating properties, offers distinct advantages for carefully selected patients. The medication's ability to improve both mood symptoms and sleep disturbances makes it particularly useful for patients experiencing depression accompanied by insomnia.\nThe relatively favorable side effect profile, particularly regarding sexual function and gastrointestinal tolerability, enhances patient acceptance and adherence to treatment. While potential side effects such as sedation, increased appetite, and weight gain require monitoring and management, many patients find these effects tolerable compared to the debilitating symptoms of untreated depression.\nSuccess with MIRTAZPRIME 30, as with any antidepressant therapy, depends on proper patient selection, appropriate dosing, regular monitoring, and a comprehensive treatment approach that may include psychotherapy, lifestyle modifications, and social support alongside pharmacological intervention. Patients should work closely with their healthcare providers to optimize treatment outcomes and maintain long-term mental health wellness.\nThe decision to use MIRTAZPRIME 30 should always be made collaboratively between patient and physician, considering individual symptoms, treatment history, coexisting medical conditions, and personal preferences. With proper use under medical supervision, MIRTAZPRIME 30 can be an effective tool in helping patients reclaim their lives from the devastating effects of depression and move toward recovery and renewed well-being.",
"price": 262.0,
"discountamount": 79.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2254,
"imageuri": "https://productimages.withfloats.com/actual/694d14f83d39ca31a28d046b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/694d14f83d39ca31a28d046b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-25T10:41:58.966Z",
"updatedon": "2026-03-13T07:46:51.004Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mirtazapine-30mg/2254",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MIRTAZPRIME 30",
"category": "NEUROLOGYRANGE",
"tags": [
"MIRTAZPRIME 30",
"Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards",
"managing depression",
"insomnia and anxiety.",
"depression or anxiety.",
"depredepressive episodes.",
"helping patients reclaim their lives from the devastating effects of depression."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6905fe704704b5ad3ff33652",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Salmeterol and Fluticasone Propionate Inhalation IP ",
"description": "Salmeterol and Fluticasone Propionate Inhalation IP is a combination medication widely used for the management and long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). This dual-acting inhalation therapy combines two powerful active ingredients — Salmeterol, a long-acting bronchodilator, and Fluticasone Propionate, a corticosteroid. Together, they work synergistically to ease breathing difficulties, control inflammation, and prevent respiratory flare-ups.\n\nIn India, respiratory diseases such as asthma and COPD affect millions of people, especially due to pollution, smoking, and changing environmental conditions. For these individuals, Salmeterol and Fluticasone Propionate Inhalation IP serves as a cornerstone therapy that offers reliable control of symptoms and improves overall lung function.\n\nComposition and Mechanism of Action\n\nThis inhalation medication contains:\n\nSalmeterol (50 mcg) – a long-acting β₂-adrenergic receptor agonist (LABA) that relaxes airway muscles, allowing air to flow more freely into the lungs.\n\nFluticasone Propionate (250 mcg or 500 mcg) – a potent corticosteroid that helps reduce inflammation, swelling, and mucus production in the airways.\n\nWhen inhaled, Salmeterol provides prolonged bronchodilation, maintaining open airways for up to 12 hours, while Fluticasone acts directly on lung tissues to minimize inflammatory responses. This dual mechanism ensures both immediate relief and long-term control of respiratory symptoms.\n\nUses of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Asthma\n\nThis combination is one of the most prescribed maintenance therapies for asthma management. It helps reduce the frequency and severity of asthma attacks, improves breathing capacity, and enables patients to lead a more active lifestyle.\n\n2. Chronic Obstructive Pulmonary Disease (COPD)\n\nIt is also indicated for COPD, including chronic bronchitis and emphysema. In these conditions, it helps relieve breathlessness, persistent cough, and wheezing, thereby improving lung efficiency and quality of life.\n\n3. Prevention of Asthma Exacerbations\n\nRegular use of this inhalation helps prevent sudden asthma flare-ups triggered by allergens, cold weather, or exercise.\n\n4. Improvement of Lung Function\n\nBy consistently controlling inflammation and relaxing airway muscles, the medication enhances FEV₁ (Forced Expiratory Volume), a measure of how efficiently a patient can exhale.\n\nKey Benefits of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Dual Therapeutic Action\n\nThe combination of a bronchodilator (Salmeterol) and an anti-inflammatory (Fluticasone) provides comprehensive control over both the causes and symptoms of respiratory conditions.\n\n2. Long-Lasting Relief\n\nWith its long-acting formulation, patients experience up to 12 hours of relief, reducing the need for frequent dosing and ensuring steady symptom control throughout the day or night.\n3. Prevention of Asthma and COPD Attacks\nRegular use helps minimize acute exacerbations, reducing hospital visits, emergency interventions, and dependency on quick-relief inhalers.\n4. Improved Breathing Comfort\n\nBy opening up constricted airways and controlling inflammation, it allows for easier breathing, better oxygen exchange, and improved stamina in daily activities.\n5. Enhanced Quality of Life\nPatients on regular inhalation therapy report fewer night-time symptoms, improved sleep, and better physical endurance, allowing them to enjoy an active, productive life.\n6. Targeted Lung Delivery\n\nAs an inhalation-based therapy, it directly delivers medication to the lungs where it’s most needed, minimizing systemic exposure and potential side effects.\n\nHow to Use\n\nShake the inhaler well before use to ensure even distribution of medicine.\n\nExhale fully and then inhale deeply through the mouthpiece while pressing down the canister to release one dose.\n\nHold your breath for a few seconds to allow the medicine to reach deep into the lungs.\n\nRinse your mouth after use to reduce the risk of fungal infections like oral thrush.\n\nPatients are advised to use the inhaler regularly at the same time each day for best results. It is not meant for sudden asthma attacks — a separate rescue inhaler should be kept for emergency relief.\n\nPossible Side Effects\n\nLike any medication, Salmeterol and Fluticasone Propionate Inhalation IP may cause mild to moderate side effects, though not everyone experiences them. Common side effects include:\n\n1. Oral and Throat Irritation\n\nDryness, irritation, or hoarseness of the throat may occur. Rinsing the mouth after use helps minimize this.\n\n2. Oral Thrush (Candidiasis)\n\nProlonged corticosteroid use can increase the risk of fungal infections in the mouth. Maintaining oral hygiene is essential.\n\n3. Headache or Dizziness\n\nSome users may experience mild headaches or lightheadedness, which typically subside over time.\n\n4. Muscle or Joint Pain\n\nOccasional mild muscle cramps or joint discomfort may occur, especially in long-term use.\n\n5. Palpitations or Tremors\n\nIn rare cases, Salmeterol may cause a slight increase in heart rate or mild tremors, particularly when the dose is higher than recommended.\n\n6. Cough or Respiratory Discomfort\n\nMild coughing or a temporary feeling of breath tightness may occur immediately after inhalation but usually passes quickly.\n\nIf any side effects persist or worsen, it is advisable to consult a healthcare professional immediately.\n\nPrecautions and Warnings\n\nNot for sudden asthma attacks — this inhaler should be used only for maintenance therapy.\n\nPregnant or breastfeeding women should use it only after medical advice.\n\nDo not exceed the prescribed dose as overuse may increase the risk of cardiovascular side effects.\n\nPatients with heart disease, hypertension, or diabetes should inform their doctor before starting treatment.\n\nAlways store the inhaler in a cool, dry place, away from direct sunlight and moisture.\n\nConclusion\n\nSalmeterol and Fluticasone Propionate Inhalation IP is a clinically proven, reliable treatment option for individuals suffering from chronic respiratory conditions like asthma and COPD. By combining the bronchodilatory power of Salmeterol with the anti-inflammatory efficacy of Fluticasone Propionate, it delivers long-term symptom control, improves lung function, and enhances quality of life.\n\nWhen used consistently and correctly under medical supervision, this inhalation therapy not only helps manage respiratory symptoms but also reduces the frequency of exacerbations and hospitalizations. For patients seeking dependable relief and sustained respiratory health, Salmeterol and Fluticasone Propionate Inhalation IP remains one of the most trusted and effective therapies available today.",
"price": 442.0,
"discountamount": 132.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2194,
"imageuri": "https://productimages.withfloats.com/actual/6905fe746e096b327485136e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6905fe746e096b327485136e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-01T12:34:56.205Z",
"updatedon": "2026-03-14T08:22:24.626Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//salmeterol-and-fluticasone-propionate-inhalation-ip-/2194",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "AIRFLOW 50 INH",
"category": "ASTHMA RANGE",
"tags": [
"Salmeterol and Fluticasone Propionate Inhalation IP",
"asthma and chronic obstructive pulmonary disease (COPD)",
"Fluticasone Propionate",
"air to flow"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "681c8454456b9f00e9d28061",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "CHARCOAL TOOTHPASTE",
"description": "Charcoal Toothpaste is a modern oral care solution formulated with activated charcoal and a blend of natural and scientifically backed ingredients. It is designed to help whiten teeth, eliminate bad breath, and remove plaque without compromising gum health. With its deep-cleansing action and refreshing flavor, it provides a comprehensive approach to maintaining oral hygiene while being gentle on teeth and gums.\n\nKey Ingredients\nAqua: Acts as a solvent and helps in blending the ingredients evenly.\n\nCalcium Carbonate PPT & Natural: Provides mild abrasion to help remove surface stains and plaque.\n\nSorbitol: A natural humectant that prevents the toothpaste from drying out.\n\nHydrated Silica: Offers gentle polishing to maintain enamel health.\n\nXylitol: A natural sweetener that also helps reduce the risk of tooth decay.\n\nSodium Saccharin: Adds sweetness without contributing to cavities.\n\nSodium Lauryl Sulfate Liquid: A foaming agent that helps disperse the paste evenly.\n\nGlycerin: Keeps the formulation smooth and moist.\n\nXanthan Gum: A natural thickener that stabilizes the formula.\n\nCharcoal: Known for its natural whitening properties and ability to draw out toxins.\n\nCoconut Oil: Supports oral health with antibacterial properties and adds a smooth texture.\n\nSodium Carboxymethyl Cellulose: Improves the texture and stability of the toothpaste.\nMethyl Paraben & Propyl Paraben: Preservatives that help maintain the shelf life.\nFlavor: Adds a pleasant and refreshing taste after brushing.\n\nKey Benefits\nHelps whiten teeth naturally by removing surface stains\n\nAids in plaque removal and reduces the risk of tartar build-up\n\nHelps fight bad breath with activated charcoal and coconut oil\n\nSupports gum health through antibacterial and soothing ingredients\n\nProvides a fresh, clean mouthfeel after every use\n\nFree from harsh chemicals that may erode tooth enamel\n\nContains xylitol, which discourages cavity-causing bacteria\n\nHow Does It Work?\nCharcoal Toothpaste works by leveraging the absorbent power of activated charcoal to bind and lift away stains and toxins from the surface of the teeth. Calcium carbonates and hydrated silica gently scrub away plaque while being safe for enamel. Coconut oil and xylitol work synergistically to fight harmful bacteria, helping to prevent cavities and gum issues. The foaming agents ensure even distribution during brushing, and flavoring agents leave the mouth feeling clean and refreshed.\n\nDirections for Use\nSqueeze a pea-sized amount of Charcoal Toothpaste onto your toothbrush\n\nBrush thoroughly for 2 minutes, preferably after meals or at least twice daily\n\nRinse mouth thoroughly with water after brushing\n\nDo not swallow\n\nFor best results, use regularly and follow with flossing and mouthwash\n\nSide Effects\nMild irritation may occur in people with sensitive gums\n\nOveruse may lead to enamel thinning due to abrasiveness if used excessively\n\nRare allergic reactions to any ingredient may cause discomfort\n\nDiscontinue use if you notice unusual sensitivity or gum bleeding and consult a dentist",
"price": 173.0,
"discountamount": 86.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"helps disperse",
"helps reduce",
"plaque removal",
"plaque sorbitol",
"discomfort discontinue",
"2 minutes preferably",
"toothbrush brush",
"peasized amount",
"refreshed directions",
"prevent cavities",
"absorbent power",
"harsh chemicals",
"refreshing taste",
"antibacterial properties",
"natural thickener",
"formulation smooth",
"natural sweetener",
"natural humectant",
"mild abrasion",
"comprehensive approach",
"refreshing flavor",
"deepcleansing action",
"charcoal toothpaste",
"formula charcoal",
"activated charcoal",
"remove plaque",
"gum bleeding",
"gum issues",
"soothing ingredients",
"foaming agent",
"remove surface stains",
"charcoal toothpastecharcoal toothpaste",
"natural whitening properties",
"xylitol work synergistically",
"teeth calcium carbonates",
"foaming agents ensure",
"moist xanthan gum",
"compromising gum health",
"scientifically backed ingredients",
"notice unusual sensitivity",
"enamel thinning due",
"sensitive gums overuse",
"daily rinse mouth",
"mouth feeling clean",
"flavoring agents leave",
"enamel coconut oil",
"discourages cavitycausing bacteria",
"erode tooth enamel",
"fresh clean mouthfeel",
"paste evenly glycerin",
"maintaining oral hygiene"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2109,
"imageuri": "https://productimages.withfloats.com/actual/681c8457f73cfba094dbc9b7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/681c8457f73cfba094dbc9b7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-08T10:15:48.815Z",
"updatedon": "2026-03-12T08:43:15.162Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//charcoal-toothpaste/2109",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Aqua, Calcium Carbonate PPT, Calcium Carbonate Natural, Sorbitol, Hydrated Silica, Xylitol, Sodium saccharin, Sodium Lauryl Sulphate Liquid, Glycerin, Xanthan Gum, Charcoal, Coconut Oil, Sodium Carboxymethyl Cellulose, Methyl Paraben, Propyl Paraben & Flavour",
"category": "DENTAL",
"tags": [
"help whiten teeth",
"bad breath",
"gum health",
"refreshing flavor",
"oral hygiene while being gentle on teeth and gums",
"Charcoal",
"Coconut Oil",
"Charcoal Toothpaste"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "66d8371d731125bdd4e105a4",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Canagliflozin 100mg",
"description": "Managing type 2 diabetes effectively requires more than just controlling blood sugar—it’s about protecting long-term health, reducing complications, and improving overall quality of life. Canagliflozin 100 mg is a modern, highly effective oral anti-diabetic medicine that belongs to the class of SGLT2 inhibitors. It is widely prescribed for its ability to lower blood sugar while also offering additional benefits like weight management and heart protection.\nIf you are considering Canagliflozin 100 mg tablet, this detailed buyer-focused guide will help you understand how it works, its benefits, dosage, precautions, and why it is becoming a preferred choice for diabetes management.\n\nWhat is Canagliflozin 100 mg?\nCanagliflozin 100 mg tablet is used to treat:\n\n\nType 2 diabetes mellitus\n\n\nHigh blood sugar levels\n\n\nPatients at risk of cardiovascular complications\n\n\nIt works by helping the body remove excess glucose through urine, which leads to improved glycemic control.\n\nHow Does Canagliflozin 100 mg Work?\nCanagliflozin works by targeting a protein in the kidneys known as SGLT2 (Sodium-Glucose Co-Transporter 2).\nMechanism of Action:\n\n\nBlocks glucose reabsorption in the kidneys\n\n\nIncreases glucose excretion through urine\n\n\nReduces blood sugar levels\n\n\nPromotes calorie loss, which may support weight reduction\n\n\nResult:\n\n\nLower fasting and post-meal glucose\n\n\nImproved HbA1c levels\n\n\nBetter overall diabetes control\n\n\n\nBuyer Intent: Why Choose Canagliflozin 100 mg?\nIf you are searching for an advanced diabetes medicine, here’s why Canagliflozin 100 mg stands out:\n1. Dual Benefit – Sugar Control + Weight Loss\nHelps lower blood sugar while also aiding in weight reduction.\n2. Heart and Kidney Protection\nProvides cardiovascular and renal benefits beyond glucose control.\n3. Once-Daily Convenience\nSimple dosing improves adherence and consistency.\n4. Works Independently of Insulin\nEffective even when insulin function is impaired.\n5. Modern & Clinically Proven\nBacked by strong clinical evidence and widely recommended by doctors.\n\nKey Benefits of Canagliflozin 100 mg\n\n\nEffectively lowers blood glucose levels\n\n\nSupports weight loss in diabetic patients\n\n\nReduces risk of heart disease\n\n\nHelps protect kidney function\n\n\nImproves insulin-independent glucose control\n\n\nMay reduce blood pressure slightly\n\n\n\nWho Should Use Canagliflozin 100 mg?\nThis medicine is suitable for:\n\n\nAdults with type 2 diabetes\n\n\nPatients not achieving control with diet and exercise alone\n\n\nIndividuals requiring combination therapy\n\n\nPatients with cardiovascular risk factors\n\n\nNote: It is not recommended for type 1 diabetes or diabetic ketoacidosis.\n\nDosage Guidelines\nRecommended Dosage:\n\n\nUsually 100 mg once daily\n\n\nTaken before the first meal of the day\n\n\nImportant Instructions:\n\n\nSwallow with water\n\n\nMaintain consistent timing\n\n\nFollow doctor’s prescription strictly\n\n\nMissed Dose:\n\n\nTake it as soon as you remember\n\n\nSkip if it’s close to the next dose\n\n\n\nPossible Side Effects\nLike all medicines, the Canagliflozin 100 mg tablet may cause some side effects.\nCommon Side Effects:\n\n\nFrequent urination\n\n\nUrinary tract infections (UTIs)\n\n\nIncreased thirst\n\n\nGenital infections\n\n\nMild dehydration\n\n\nLess Common Side Effects:\n\n\nDizziness\n\n\nConstipation\n\n\nNausea\n\n\n\nSerious Side Effects (Rare but Important)\n\n\nSevere dehydration\n\n\nKidney problems\n\n\nKetoacidosis (rare but serious)\n\n\nSevere infections\n\n\nSeek immediate medical help if you experience symptoms like abdominal pain, vomiting, or unusual fatigue.\n\nPrecautions & Warnings\nBefore taking Canagliflozin 100 mg, consider the following:\n1. Kidney Function\n\n\nNot recommended in severe kidney impairment\n\n\n2. Hydration\n\n\nDrink enough fluids to prevent dehydration\n\n\n3. Infections\n\n\nMaintain hygiene to reduce risk of infections\n\n\n4. Alcohol\n\n\nLimit alcohol intake\n\n\n5. Pregnancy & Breastfeeding\n\n\nUse only if prescribed\n\n\n\nDrug Interactions\nCanagliflozin may interact with:\n\nDiuretics (water pills)\n\n\nInsulin and other anti-diabetic drugs\n\n\nBlood pressure medications\nAlways inform your doctor about your current medications.\nLifestyle Tips for Better Results\nTo maximize the effectiveness of Canagliflozin 100 mg, follow these tips:\n\n\nMaintain a healthy diet\n\nExercise regularly\n\n\nMonitor blood sugar levels\n\n\nStay hydrated\n\n\nAvoid excessive sugar intake\n\nFrequently Asked Questions (FAQs)\nQ1: What is Canagliflozin 100 mg used for?\nIt is used to manage blood sugar levels in type 2 diabetes.\nQ2: Does it help in weight loss?\nYes, it may help reduce weight by eliminating excess glucose.\nQ3: Can it be taken with other diabetes medicines?\nYes, but only under medical supervision.\nQ4: How quickly does it work?\nIt starts working within a few days, but full benefits take a few weeks.\nQ5: Is it safe for long-term use?\nYes, when taken as prescribed by a doctor.\nBuying Guide: What to Consider Before Purchase\nBefore buying Canagliflozin 100 mg tablets, ensure:\n\n\nIt is prescribed by a qualified doctor\n\n\nPurchase from a reliable pharmacy\n\nCheck packaging and expiry date\n\nStore in a cool, dry place\n\nConclusion\nCanagliflozin 100 mg is a modern and highly effective solution for managing type 2 diabetes. With its unique mechanism of removing excess glucose through urine, it not only controls blood sugar but also offers additional benefits like weight loss, heart protection, and kidney support.\nFor patients looking for a comprehensive diabetes management solution, this medicine stands out as a powerful and convenient option. Always use it under medical supervision and combine it with a healthy lifestyle to achieve the best results.\n",
"price": 618.0,
"discountamount": 185.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"one tablet",
"weight loss",
"Key Benefits",
"dual benefit",
"transporter 2",
"SGLT2 protein",
"typical dosage",
"GLICANA FLOZIN",
"kidney problems",
"type 2 diabetes",
"unusual symptoms",
"effective option",
"glucose excretion",
"SGLT2) inhibitors",
"Weight Management",
"regular monitoring",
"blood sugar levels",
"healthcare provider",
"Common side effects",
"blood sugar control",
"glucose reabsorption",
"Serious side effects",
"cardiovascular events",
"many diabetic patients",
"Reduced Blood Pressure",
"prescription medication",
"heart health protection",
"urinary tract infections",
"optimal glycemic control",
"Cardiovascular Protection",
"additional health benefit",
"severe allergic reactions",
"Effective Glycemic Control",
"overall glycemic management",
"additional glycemic control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1959,
"imageuri": "https://productimages.withfloats.com/actual/69e72879a950890b18bae2f7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69e72879a950890b18bae2f7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-04T10:31:57.994Z",
"updatedon": "2026-04-21T07:34:17.189Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//canagliflozin-100mg/1959",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLICANA FLOZIN 100",
"category": "DIABETIC RANGE",
"tags": [
"Canagliflozin 100mg uses in hindi",
"canagliflozin 100 mg side effects",
"Canagliflozin 100mg",
"canagliflozin 100mg",
"Canagliflozin 100mg tablet uses in type 2 diabetes",
"How does canagliflozin 100mg work",
"Best time to take canagliflozin 100mg",
"canagliflozin 100 mg price",
"canagliflozin 100 mg brands in india",
"canagliflozin 100 mg tablet",
"canagliflozin 100 mg price in india",
"tab canagliflozin 100 mg uses",
"canagliflozin 100 mg india",
"canagliflozin 100 mg uses price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6662e74687f0960e14a2d95a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Gefitinib 250mg",
"description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n",
"price": 2760.0,
"discountamount": 828.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"food",
"Call",
"Uses",
"Rash",
"Note",
"NSCLC",
"Email",
"nausea",
"Dosage",
"spread",
"WhatsApp",
"diarrhea",
"Gefitinib",
"treatment",
"One tablet",
"GEFISTERIS",
"information",
"sterispharma",
"consultation",
"sterisonline",
"Side Effects",
"cancer cells",
"targeted therapy",
"Regular monitoring",
"healthcare provider",
"small cell lung cancer",
"healthcare professional",
"specific EGFR mutations",
"epidermal growth factor receptor",
"potential liver function alterations"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1530,
"imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T10:56:06.808Z",
"updatedon": "2026-04-15T10:04:00.767Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GEFISTERIS 250",
"category": "Oncology",
"tags": [
"gefitinib 250 mg uses",
"gefitinib 250 mg online purchase",
"gefitinib 250 mg tablets price in india",
"non-small cell lung cancer (NSCLC).",
"triggered by chemotherapy.",
"cancer biology.",
"Superior Efficacy in EGFR-Mutant NSCLC",
"gefitinib 250mg",
"gefitinib 250mg tablet",
"gefitinib 250mg tab",
"gefitinib 250 mg tablet uses in lung cancer",
"gefitinib tablets 250 mg dosage and benefits",
"gefitinib 250 mg price in india",
"gefitinib 250 mg EGFR inhibitor for NSCLC treatment india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "665ed10e8da3a81d5c69dece",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "dapagliflozin and vildagliptin tablets",
"description": "Introduction\n\nDapagliflozin and Vildagliptin tablets are a modern combination medicine used for the effective management of Type 2 Diabetes Mellitus (T2DM). This dual-action therapy combines two proven antidiabetic agents that work through different mechanisms to help control blood sugar levels, improve insulin function, and reduce the risk of diabetes-related complications.\n\nAs Type 2 diabetes continues to affect millions of people worldwide, healthcare providers increasingly recommend combination therapies that target multiple pathways involved in glucose regulation. Dapagliflozin and Vildagliptin tablets offer comprehensive glycemic control while supporting overall metabolic health.\n\nThis combination is generally prescribed to adults whose blood sugar levels are not adequately controlled through diet, exercise, or single-drug therapy. By addressing different aspects of glucose metabolism, it helps patients achieve better long-term diabetes management.\n\nWhat Are Dapagliflozin and Vildagliptin Tablets?\n\nDapagliflozin and Vildagliptin tablets contain two active pharmaceutical ingredients:\n\nDapagliflozin\n\nDapagliflozin belongs to a class of medicines known as SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitors. It works by helping the kidneys remove excess glucose from the bloodstream through urine.\n\nVildagliptin\n\nVildagliptin belongs to the DPP-4 (Dipeptidyl Peptidase-4) inhibitor class. It enhances the body's natural incretin hormones, which help regulate insulin production and reduce excess glucose production by the liver.\n\nTogether, these medications provide a complementary approach to blood sugar control, making them highly effective for patients with Type 2 diabetes.\n\nHow Dapagliflozin and Vildagliptin Tablets Work\n\nThe effectiveness of this combination lies in its dual mechanism of action.\n\nAction of Dapagliflozin\n\nDapagliflozin blocks the SGLT2 proteins in the kidneys responsible for reabsorbing glucose into the bloodstream.\n\nThis leads to:\n\nIncreased glucose excretion through urine\nLower blood sugar levels\nReduction in fasting and post-meal glucose\nPotential weight reduction\nLower blood pressure in some patients\nAction of Vildagliptin\n\nVildagliptin increases levels of incretin hormones, which:\n\nStimulate insulin release when blood sugar rises\nReduce glucagon secretion\nDecrease liver glucose production\nImprove pancreatic beta-cell function\n\nThe combination provides continuous glucose regulation throughout the day.\n\nUses of Dapagliflozin and Vildagliptin Tablets\n\nDapagliflozin and Vildagliptin tablets are primarily prescribed for:\n\n1. Type 2 Diabetes Mellitus\n\nThe medication helps control elevated blood sugar levels in adults diagnosed with Type 2 diabetes.\n\n2. Inadequate Glycemic Control\n\nIt is often prescribed when lifestyle modifications and single-drug treatments fail to achieve target HbA1c levels.\n\n3. Combination Diabetes Therapy\n\nHealthcare professionals may recommend this medicine as part of a comprehensive diabetes management plan.\n\n4. Long-Term Blood Sugar Management\n\nRegular use helps maintain stable blood glucose levels and reduces fluctuations.\n\n5. Prevention of Diabetes Complications\n\nProper glycemic control can lower the risk of:\n\nKidney damage\nNerve damage\nVision problems\nCardiovascular complications\nKey Benefits of Dapagliflozin and Vildagliptin Tablets\nSuperior Blood Sugar Control\n\nThe combination attacks high blood sugar through two independent mechanisms, resulting in improved glycemic management.\n\nBenefits include:\nReduced fasting blood glucose\nImproved postprandial glucose levels\nLower HbA1c values\nBetter daily glucose stability\nSupports Weight Management\n\nUnlike some traditional diabetes medications, Dapagliflozin helps eliminate excess glucose through urine, which may contribute to modest weight reduction in certain patients.\n\nPatients with Type 2 diabetes who are overweight may find this particularly beneficial.\n\nLow Risk of Hypoglycemia\n\nWhen used appropriately, Dapagliflozin and Vildagliptin have a relatively low risk of causing severe hypoglycemia compared to some older antidiabetic medications.\n\nThis improves treatment safety and patient confidence.\n\nImproves Insulin Efficiency\n\nVildagliptin enhances the body's natural insulin response only when glucose levels rise.\n\nThis physiological mechanism helps maintain balanced blood sugar control.\n\nBetter Patient Compliance\n\nInstead of taking multiple separate medicines, patients can benefit from a convenient fixed-dose combination tablet.\n\nAdvantages include:\n\nSimplified treatment regimen\nImproved adherence\nReduced medication burden\nBetter long-term outcomes\nCardiometabolic Benefits\n\nDapagliflozin has demonstrated additional benefits beyond blood sugar control, including:\n\nSupport for cardiovascular health\nBlood pressure reduction\nImproved metabolic profile\nReduced glucose toxicity\nKidney-Friendly Glucose Reduction Mechanism\n\nBecause Dapagliflozin lowers glucose through urinary excretion, it operates independently of insulin pathways, providing effective support even in patients with insulin resistance.\n\nWho May Benefit from Dapagliflozin and Vildagliptin Tablets?\n\nThis medication may be suitable for:\n\nAdults with Type 2 Diabetes Mellitus\nPatients requiring dual oral antidiabetic therapy\nIndividuals with inadequate control on monotherapy\nOverweight diabetic patients\nPatients seeking convenient combination treatment\n\nHowever, treatment decisions should always be made by a qualified healthcare professional.\n\nRecommended Usage Guidelines\n\nFor optimal results:\n\nTake the tablet exactly as prescribed.\nFollow dietary recommendations.\nMaintain regular physical activity.\nMonitor blood glucose regularly.\nAttend scheduled medical checkups.\nStay adequately hydrated.\n\nConsistency is essential for achieving long-term glycemic control.\n\nPossible Side Effects of Dapagliflozin and Vildagliptin Tablets\n\nLike all medications, Dapagliflozin and Vildagliptin tablets may cause side effects in some individuals.\n\nCommon Side Effects\n\nThese may include:\n\nFrequent urination\nIncreased thirst\nHeadache\nDizziness\nNausea\nFatigue\nMild stomach discomfort\n\nThese symptoms are generally mild and temporary.\n\nUrinary Tract Infections\n\nBecause Dapagliflozin increases glucose excretion through urine, some patients may experience:\n\nUrinary tract infections (UTIs)\nIncreased urination frequency\nBurning sensation during urination\n\nPrompt medical attention should be sought if symptoms persist.\n\nGenital Fungal Infections\n\nSome individuals may develop fungal infections due to increased urinary glucose levels.\n\nMaintaining good hygiene can help reduce risk.\n\nDehydration\n\nIncreased urination may lead to:\n\nDry mouth\nExcessive thirst\nLightheadedness\nWeakness\n\nAdequate fluid intake is recommended.\n\nRare Side Effects\n\nAlthough uncommon, serious side effects may include:\n\nSevere allergic reactions\nPancreatitis\nSignificant kidney problems\nLiver enzyme abnormalities\nDiabetic ketoacidosis\n\nPatients should immediately consult a healthcare provider if unusual symptoms occur.\n\nPrecautions Before Using Dapagliflozin and Vildagliptin Tablets\n\nPatients should inform their healthcare provider about:\n\nKidney disease\nLiver disorders\nHeart conditions\nPancreatic disorders\nHistory of recurrent infections\nCurrent medications\n\nSpecial caution may be necessary for elderly patients and those with impaired renal function.\n\nLifestyle Tips for Better Diabetes Management\n\nMedication works best when combined with healthy lifestyle habits.\n\nFollow a Balanced Diet\n\nFocus on:\n\nWhole grains\nFresh vegetables\nLean proteins\nHealthy fats\nControlled carbohydrate intake\nStay Physically Active\n\nRegular exercise can:\n\nImprove insulin sensitivity\nSupport weight management\nEnhance cardiovascular health\nMonitor Blood Sugar Levels\n\nRoutine monitoring helps:\n\nTrack treatment effectiveness\nIdentify glucose fluctuations\nGuide treatment adjustments\nMaintain Regular Medical Checkups\n\nPeriodic assessments help evaluate:\n\nHbA1c levels\nKidney function\nLiver function\nOverall diabetes control\nFrequently Asked Questions (FAQs)\nWhat is Dapagliflozin and Vildagliptin used for?\n\nIt is used to improve blood sugar control in adults with Type 2 Diabetes Mellitus.\n\nCan it replace diet and exercise?\n\nNo. The medication works best alongside proper nutrition and regular physical activity.\n\nDoes it cause weight gain?\n\nGenerally, Dapagliflozin may support modest weight reduction rather than weight gain.\n\nIs it suitable for Type 1 diabetes?\n\nNo. This combination is intended for Type 2 Diabetes Mellitus and should only be used under medical supervision.\n\nHow long does it take to show results?\n\nBlood sugar improvements may begin within days, while HbA1c improvements are typically evaluated over several weeks to months.\n\nConclusion\n\nDapagliflozin and Vildagliptin tablets represent an advanced and effective treatment option for adults managing Type 2 Diabetes Mellitus. By combining the glucose-lowering benefits of an SGLT2 inhibitor with the insulin-enhancing effects of a DPP-4 inhibitor, this therapy offers comprehensive blood sugar control through complementary mechanisms.",
"price": 130.0,
"discountamount": 39.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"diet",
"risk",
"part",
"EMAIL",
"goals",
"needs",
"Order",
"GLP-1",
"adults",
"action",
"target",
"adjunct",
"kidneys",
"patients",
"exercise",
"other hand",
"dapa-vilda",
"convenient",
"monotherapy",
"information",
"supervision",
"hypoglycemia",
"DPP-4 enzyme",
"sterispharma",
"side effects",
"tolerability",
"sterisonline",
"CALL/WHATSAPP",
"transporter 2",
"Dapagliflozin",
"sodium-glucose",
"Vildagliptin SR",
"adverse effects",
"SGLT2) inhibitor",
"glycemic control",
"glucagon release",
"DPP-4) inhibitor",
"insulin secretion",
"incretin hormones",
"dosage adjustments",
"individual patient",
"different pathways",
"glucose metabolism",
"DAPA VILDA 5/100 SR",
"individual response",
"dual therapy option",
"daily dosing option",
"synergistic approach",
"glucose reabsorption",
"uncontrolled diabetes",
"two active ingredients",
"dipeptidyl peptidase-4",
"comprehensive approach",
"combination medication",
"healthcare professional",
"long-term complications",
"urinary tract infections",
"type 2 diabetes mellitus",
"urinary glucose excretion",
"genital mycotic infections",
"lower blood glucose levels",
"sustained-release formulation",
"gastrointestinal disturbances",
"additional glucose-lowering agents",
"comprehensive diabetes management plan"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1274,
"imageuri": "https://productimages.withfloats.com/actual/665ed12ffb1d1538612033fd.png",
"tileimageuri": "https://productimages.withfloats.com/tile/665ed12ffb1d1538612033fd.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-04T08:32:14.71Z",
"updatedon": "2026-06-05T07:44:58.851Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-and-vildagliptin-tablets/1274",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DAPA VILDA 5/100 SR ",
"category": "DIABETIC RANGE",
"tags": [
"dapagliflozin and vildagliptin sustained release tablets uses",
"dapagliflozin and vildagliptin sustained release tablets",
"dapagliflozin and vildagliptin",
"dapagliflozin and vildagliptin tablet uses",
"dapagliflozin and vildagliptin tablet",
"dapagliflozin and vildagliptin uses",
"dapagliflozin and vildagliptin sustained release tablets in hindi",
"dapagliflozin and vildagliptin sr tablets uses",
"can dapagliflozin and vildagliptin taken together",
"dapagliflozin and vildagliptin combination brands",
"dapagliflozin and vildagliptin combination uses",
"dapagliflozin and vildagliptin tablets price",
"dapagliflozin vildagliptin metformin brands in india",
"dapagliflozin and vildagliptin uses in hindi",
"dapagliflozin and vildagliptin use"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}